Core Viewpoint - SelectQuote, Inc. is facing a securities class action lawsuit for failing to disclose material information during the class period from September 9, 2020, to May 1, 2025, which has implications for investors who purchased the company's securities during this time [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the United States District Court for the Southern District of New York, with a deadline for lead plaintiff applications set for October 10, 2025 [1]. - The case is titled Pahlkotter v. SelectQuote, Inc., et al., No. 25-cv-06620 [5]. - The U.S. Department of Justice filed a False Claims Act complaint against SelectQuote, alleging the company received "tens of millions of dollars" in illegal kickbacks from health insurance companies from 2016 to at least 2021 [4]. Group 2: Allegations Against SelectQuote - The DOJ claims that SelectQuote engaged in a conspiracy with major insurers to illegally discriminate against less profitable beneficiaries, including those with disabilities [4]. - The company allegedly misrepresented its services by claiming to offer "unbiased coverage comparisons," while directing Medicare beneficiaries to plans that provided the highest kickbacks [4]. - Following the DOJ's allegations, SelectQuote's share price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, amid heavy trading volume [4]. Group 3: Investor Resources - ClaimsFiler provides a free service for investors to access information regarding securities class action settlements and encourages affected investors to register for updates [6]. - Investors can upload their portfolio transactional data to receive notifications about relevant securities cases [6]. - Legal assistance is available through Kahn Swick & Foti, LLC for those seeking to understand their options regarding the lawsuit [2].